Intensity Therapeutics, Inc. announced on May 28, 2025, a collaboration with Christine Handy, an author, model, executive producer, speaker, and breast cancer survivor. The partnership aims to educate patients with early-stage breast cancer about potential new therapeutic options, including Intensity's investigational drug INT230-6. Handy's novel, 'Walk Beside Me,' which inspired the film 'Hello Beautiful,' recently won the Golden Palm Award at the Beverly Hills Film Festival.
Christine Handy, who was diagnosed with aggressive breast cancer in 2012, expressed her passion for supporting women navigating breast cancer treatment. She highlighted the hope offered by novel tumor-injection therapies like INT230-6, envisioning a future beyond current harsh cancer treatments.
Lewis H. Bender, Intensity Therapeutics' CEO, stated that the collaboration is a natural fit, aligning with the company's mission to improve the lives of cancer patients. This initiative is expected to bring greater understanding to presurgical cancer patients about new treatment potentials, particularly as the Phase 2 INVINCIBLE-4 trial progresses for triple-negative breast cancer.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.